Colinz Laboratories Ltd.
Snapshot View

50.50 +0.80 ▲1.6%

28 November 2022, 04:01:00 PM
Volume: 521

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.findoc-cll.in
Market Cap 12.72 Cr.
Enterprise Value(EV) 7.58 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 1.52 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 33.13 Trailing Twelve Months Ending 2022-09
Industry PE 35.11 Trailing Twelve Months Ending 2022-09
Book Value / Share 31.58 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.60 Calculated using Price: 50.50
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.25 Cr. 2,519,100 Shares
FaceValue 10
Company Profile
Pharmaceutical Formulations (of all dosages forms) TabletsCapsulesParenteralsCreams/ Ointments/LotionsDry PowderLiquid OralsSoft Gelatine Capsules

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.61%
1 Week
-2.88%
1 Month
+3.38%
3 Month
+43.87%
6 Month
+87.04%
1 Year
+163.02%
2 Year
+443.01%
5 Year
+145.74%
10 Year
+547.44%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 1.06 1.55 1.52 2.21 3.48 1.79 1.91 2.94 4.53
Return on Capital Employed (%) 2.52 3.12 3.27 3.12 3.25 3.45 3.30 4.28 6.76
Return on Assets (%) 0.67 0.94 0.93 1.45 2.39 1.30 1.45 2.20 3.39

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 6 6 6 7 7 7 7 7 8 8
Non Curr. Liab. 2 3 2 1 1 1 0 0 0 0
Curr. Liab. 1 2 1 2 2 2 2 3 2 2
Minority Int.
Equity & Liab. 10 11 10 10 10 9 9 10 10 11
Non Curr. Assets 6 5 4 4 4 4 3 3 3 3
Curr. Assets 4 6 5 5 6 6 6 7 7 8
Misc. Exp. not W/O
Total Assets 10 11 10 10 10 9 9 10 10 11

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 7 8 8 8 8 8 8 6 7 7
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 8 8 8 8 8 8 8 6 7 7
Total Expenditure -7 -7 -8 -8 -8 -7 -7 -6 -6 -6
PBIDT 0 1 1 1 0 0 0 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 0 0 0 1 0 0 1 1 1

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 1 0 1 0 0 0 1 2 0
Cash Fr. Inv. 0 0 0 0 0 0 0
Cash Fr. Finan. 0 0 0 -1 0 0 0 0 0 0
Net Change 0 0 1 0 0 0 0 1 2 1
Cash & Cash Eqvt 1 1 2 2 2 2 2 3 5 5

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 36.42 36.42 36.42 36.42 36.41 36.41 36.38 66.01 65.93
Public 63.58 63.58 63.58 63.58 63.59 63.59 63.62 33.99 34.07
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 01 Nov 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith Newspaper clippings of Un-Audited Financial Results for the quarter and half year ended on 30th September 2022 published in FREE PRESS JOURNAL and NAVSHAKTI on 1st November 2022 in pursuance of Regulation 47(3) of SEBI (Listing obligations and Disclosure Requirements) Regulations 2015 which were approved in the Board meeting held on 31st October 2022.
Mon, 31 Oct 2022
Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.
We would like to inform you that the Board of Directors of the Company at their meeting held today i.e. 31st October 2022 has inter alia considered and approved Unaudited Financial Results (as per IND-AS) for the quarter and half year ended on 30th September 2022.Enclosed herewith the same (Unaudited Financial Results for the quarter and half year ended on 30th September 2022) along with a Limited Review Report dated 31st October 2022 issued by M/s. Vora & Associates Chartered Accountants and Statutory Auditors of the Company with respect to Unaudited Financial Results for the quarter and half year ended on 30th September 2022.The Meeting commenced at 3:30 PM and concluded at 4.30 p.m.
Mon, 31 Oct 2022
Outcome Of The Board Meeting Under Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.<BR> <BR>
We would like to inform you that the Board of Directors of the Company at their meeting held today i.e. 31st October 2022 has inter alia considered and approved Unaudited Financial Results (as per IND-AS) for the quarter and half year ended on 30th September 2022.

Enclosed herewith the same (Unaudited Financial Results for the quarter and half year ended on 30th September 2022) along with a Limited Review Report dated 31st October 2022 issued by M/s. Vora & Associates Chartered Accountants and Statutory Auditors of the Company with respect to Unaudited Financial Results for the quarter and half year ended on 30th September 2022.

The Meeting commenced at 3:30 PM and concluded at 4.30 p.m.

Technical Scans View Details >>

Mon, 28 Nov 2022
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
High Increase 3 Months High Increase 3 Months
High Increase 6 Months High Increase 6 Months
High Increase 1 Year High Increase 1 Year
High Increase 2 Years High Increase 2 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 248,271.19 1,034.75 +0.1%
Divi's Laboratories Ltd. 89,610.25 3,375.55 +1.0%
Cipla Ltd. 88,883.00 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. 73,293.35 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. 67,892.96 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. 55,408.60 1,637.15 +0.6%
Max Healthcare Institute Ltd. 42,945.22 442.70 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.34 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 29.96 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-09 34.64 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.57 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 80.92 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.52 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-09 45.51 442.70 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.66 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.39 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-09 4.06 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.53 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.35 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.10 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-09 6.21 442.70 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 442.70 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 442.70 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 442.70 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 442.70 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 442.70 +2.6%

FAQ's On Colinz Laboratories Ltd.

What is Colinz Laboratories share price?

Can I buy Colinz Laboratories shares now?

What is the Market Cap of Colinz Laboratories?

What are the key metrics to analyse Colinz Laboratories?

What is the 52 Week High and Low of Colinz Laboratories?

What is the trend of Colinz Laboratories share price?